Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D004232:Diuretics / Q000009:adverse effects; D004347:Drug Interactions; D005858:Germany; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D013148:Spironolactone / Q000009:adverse effects*
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D013148:Spironolactone